RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. R1 Therapeutics

R1 Therapeutics

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

Latest funding

$80.5M Series A ·

Led by Samsara Biocapital · Source: clinicaltrialsarena.com

Total raised: $158M across 2 sourced rounds

All 2 rounds ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics.
Stage: Series A.
Based in: London, United Kingdom.
Founded: 2024.
Total raised: $158M in 2 sourced rounds.
Last round: Sep 30, 2026 · 49 days ago.
Headcount: 1–10 employees.
On Recent Funding since: Oct 4, 2026.

Signals

Website registeredSep 22, 2025 (14 months old)
TIMELINE · MONEY RAISED

R1 Therapeutics | 176 days from website to first raise on record

Raised $158M in 2 sourced rounds·1 signal before the first raise
$40M$79M$119M$158MOCTDECFEBAPRJUNAUGOCTDEC$158M||WEBSITE CREATED · SEP 22, 2025$77.5M Series A · Mar 17, 2026$77.5M A · MAR '26$80.5M Series A · Sep 30, 2026$80.5M A · SEP '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$80.5MSSamsara Biocapitalclinicaltrialsarena.com
Series A$77.5MAAbingworthpharmiweb.com

Timeline

  1. Website created

Founders and team

Investors

Companies like R1 Therapeutics

Other companies backed by Samsara Biocapital

Samsara Biocapital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/r1-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy